Insiders · Profile

Reardon Andrew

CLO & Secretary at LIGAND PHARMACEUTICALS. Filing since 24 Mar 2023. CIK 0001950232

Company

Date

Role

Action

Shares

Amount

Of holding

LGND LIGAND PHARMACEUTICALS INC

2 Oct 2026

CLO & Secretary

Sold on a plan

5,000

$1.52M

13.6%

LGND LIGAND PHARMACEUTICALS INC

3 Sep 2026

CLO & Secretary

Sold on a plan

5,000

$1.43M

12.0%

LGND LIGAND PHARMACEUTICALS INC

3 Aug 2026

CLO & Secretary

Sold on a plan

5,000

$1.44M

10.7%

LGND LIGAND PHARMACEUTICALS INC

1 Jul 2026

CLO & Secretary

Sold on a plan

5,000

$1.57M

10.7%

LGND LIGAND PHARMACEUTICALS INC

1 Jun 2026

CLO & Secretary

Sold on a plan

5,000

$1.14M

10.8%

LGND LIGAND PHARMACEUTICALS INC

1 May 2026

CLO & Secretary

Sold on a plan

5,000

$1.16M

10.8%

LGND LIGAND PHARMACEUTICALS INC

1 Apr 2026

CLO & Secretary

Sold on a plan

5,000

$1.01M

10.8%

LGND LIGAND PHARMACEUTICALS INC

4 Mar 2026

CLO & Secretary

Sold on a plan

5,000

$1.03M

11.9%

LGND LIGAND PHARMACEUTICALS INC

23 Jun 2025

CLO & Secretary

Sold at will

500

$57.04K

1.5%

LGND LIGAND PHARMACEUTICALS INC

10 Jun 2025

CLO & Secretary

Sold at will

500

$57.27K

1.5%

LGND LIGAND PHARMACEUTICALS INC

15 May 2025

CLO & Secretary

Sold at will

1,000

$104.00K

2.9%

LGND LIGAND PHARMACEUTICALS INC

23 Sep 2024

CLO & Secretary

Sold at will

2,000

$199.20K

8.2%

LGND LIGAND PHARMACEUTICALS INC

28 Aug 2024

CLO & Secretary

Sold at will

1,500

$159.59K

6.2%

LGND LIGAND PHARMACEUTICALS INC

9 May 2024

Chief Legal Officer &

Sold at will

10,000

$830.45K

31.1%

LGND LIGAND PHARMACEUTICALS INC

24 Mar 2023

See Remarks

Sold at will

300

$20.98K

1.8%

15 decisions on file.